Clinical Trials

Non-Squamous Non-Small Cell Lung Cancer

NCT03802240 2023-11-27

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

492 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT00760929 2021-01-05

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Phase 2 Terminated

171 enrolled 17 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02008227 2019-12-20

OAK

1,225 enrolled 32 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01260181 2018-10-31

A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

30 enrolled 13 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01174563 2018-09-17

A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

60 enrolled 9 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01310036 2018-09-12

A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

208 enrolled 12 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01893268 2018-05-14

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice

279 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01378962 2018-01-23

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)

50 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01995188 2017-10-04

A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

41 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

485 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01723878 2017-09-11

ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations

144 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01827852 2017-07-28

AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung

1,107 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01836133 2017-05-04

ELEMENT

70 enrolled 8 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01702714 2016-11-04

A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease

Phase 1 Withdrawn

Non-Squamous Non-Small Cell Lung Cancer

NCT00642824 2016-11-02

A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Phase 2 Terminated

3 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT00773188 2016-11-02

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

6 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT00776698 2016-11-02

A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

1 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT00974584 2016-11-02

A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

65 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01070927 2016-11-02

An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

7 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01194050 2016-11-02

An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer

289 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01343914 2016-11-02

An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

118 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01456325 2016-11-02

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

494 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01488331 2016-11-02

An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer

217 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01512420 2016-11-02

An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)

355 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01790217 2016-11-02

An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)

52 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01887886 2016-11-02

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

10 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01328951 2016-10-28

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

643 enrolled 16 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01496742 2016-09-23

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

259 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01519804 2016-09-02

A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer

108 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01066884 2016-08-24

A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer

Phase 4 Completed

5 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT02774278 2016-08-08

MERIT

264 enrolled 9 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00642473 2016-05-23

MATER

34 enrolled 8 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02596958 2016-04-04

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

996 enrolled 14 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01250119 2016-03-14

A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.

688 enrolled 10 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00961415 2016-02-22

AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer

376 enrolled 14 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01185847 2016-01-01

A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

90 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01664533 2015-12-28

TIME

57 enrolled 10 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00883779 2015-12-14

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

451 enrolled 23 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01204697 2015-11-16

A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)

74 enrolled 12 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01535729 2015-10-29

An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

465 enrolled 25 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01077713 2015-10-08

A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer

86 enrolled 16 charts